Brief: Seoul Pharma signs contract worth 111.08 bln won
22/06/2017 09:22
June 22 (Reuters) - Seoul Pharma Co Ltd 018680.KQ :
* Says it signed a 111.08 billion won contract with Suzhou
Guang'ao healthcare Co., Ltd to provide medicine ODF in China
Source text in Korean: https://goo.gl/3ydsqY
Further company coverage: 018680.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))
Recent news on Seoul Pharma
See all newsBrief: Seoul Pharma Says Terminates Contract Worth $5.3 Million To Supply Erectile Dysfunction Drugs In Middle East Region
Brief: Seoul Pharma appoints CEO
Brief: Seoul Pharma issues 3rd tranche convertible bonds worth 6 bln won
Brief: Seoul Pharma signs contract worth 7.86 bln won
Brief: Seoul Pharma signs contract worth 8.62 bln won